TrialBreast cancer research : BCR2016

Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).

Stefanie de Groot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.